ZICOTZEK MED: what changed
ZICOTZEK MED
Largest movements
- Cash +€4,391
up €4,391 (+9.4%), from €46,795 to €51,186
mainly Net result for the year (+€33,652) and Other debts (+€4,806)
- Deferred charges and accrued income +€994
new in 2024: €994
- Receivables within one year +€593
new in 2024: €593
- Other debts +€4,806
up €4,806 (+19.1%), from €25,194 to €30,000
- Profit (loss) carried forward +€3,652
up €3,652 (+25.6%), from €14,239 to €17,891
- Tax, wage and social debts -€1,950
down €1,950 (-57.2%), from €3,411 to €1,460
of which Remuneration and social security: -€3,025
- Trade debts -€651
no longer reported in 2024 (was €651)
- Gross operating margin +€10,764
up €10,764 (+40.7%), from €26,436 to €37,200
- Staff costs -€2,341
down €2,341 (-97.0%), from €2,414 to €73
- Taxes +€1,159
up €1,159 (+385%), from €301 to €1,460
- Other operating charges -€423
down €423 (-67.0%), from €632 to €209
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,495 | €54,351 | +€5,856 | +12.1% |
| Fixed assets | 21/28 | €1,700 | €1,578 | -€122 | -7.2% |
| Tangible fixed assets | 22/27 | €1,369 | €1,578 | +€209 | +15.3% |
| Plant, machinery and equipment | 23 | €1,369 | - | -€1,369 | |
| Furniture and vehicles | 24 | - | €1,578 | +€1,578 | |
| Financial fixed assets | 28 | €331 | - | -€331 | |
| Current assets | 29/58 | €46,795 | €52,773 | +€5,978 | +12.8% |
| Amounts receivable within one year | 40/41 | - | €593 | +€593 | |
| Other amounts receivable | 41 | - | €593 | +€593 | |
| Cash at bank and in hand | 54/58 | €46,795 | €51,186 | +€4,391 | +9.4% |
| Deferred charges and accrued income | 490/1 | - | €994 | +€994 | |
| Total equity and liabilities | 10/49 | €48,495 | €54,351 | +€5,856 | +12.1% |
| Equity | 10/15 | €19,239 | €22,891 | +€3,652 | +19.0% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €14,239 | €17,891 | +€3,652 | +25.6% |
| Amounts payable | 17/49 | €29,256 | €31,460 | +€2,205 | +7.5% |
| Amounts payable within one year | 42/48 | €29,256 | €31,460 | +€2,205 | +7.5% |
| Trade debts | 44 | €651 | - | -€651 | |
| Suppliers | 440/4 | €651 | - | -€651 | |
| Taxes, remuneration and social security | 45 | €3,411 | €1,460 | -€1,950 | -57.2% |
| Taxes | 450/3 | €386 | €1,460 | +€1,075 | +279% |
| Remuneration and social security | 454/9 | €3,025 | - | -€3,025 | |
| Other amounts payable | 47/48 | €25,194 | €30,000 | +€4,806 | +19.1% |
| Remuneration, social security and pensions | 62 | €2,414 | €73 | -€2,341 | -97.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,369 | €1,630 | +€261 | +19.1% |
| Other operating charges | 640/8 | €632 | €209 | -€423 | -67.0% |
| Gross operating margin | 9900 | €26,436 | €37,200 | +€10,764 | +40.7% |
| Operating profit (loss) | 9901 | €22,022 | €35,288 | +€13,266 | +60.2% |
| Financial charges | 65/66B | €198 | €176 | -€22 | -10.9% |
| Recurring financial charges | 65 | €198 | €176 | -€22 | -10.9% |
| Profit (loss) for the period before taxes | 9903 | €21,824 | €35,112 | +€13,288 | +60.9% |
| Income taxes | 67/77 | €301 | €1,460 | +€1,159 | +385% |
| Profit (loss) for the period | 9904 | €21,523 | €33,652 | +€12,129 | +56.4% |
| Profit (loss) for the period to be appropriated | 9905 | €21,523 | €33,652 | +€12,129 | +56.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.